SMTL ID : 4a79.1

Crystal structure of human monoamine oxidase B (MAO B) in complex with pioglitazone

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

homo-dimer

Ligands

2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Covalent)

FAD.1: 37 residues within 4Å: Chain A: V.10, G.11, G.12, G.13, I.14, S.15, L.33, E.34, A.35, R.36, G.40, G.41, R.42, T.43, L.56, G.57, G.58, S.59, Y.60, R.233, P.234, V.235, A.263, I.264, P.265, L.268, W.388, Y.393, C.397, Y.398, G.425, T.426, G.434, Y.435, M.436, A.439 Ligands: P1B.2 31 PLIP interactions: 31 interactions with chain A Hydrophobic interactions: A:W.388, A:Y.398 Hydrogen bonds: A:G.12, A:G.13, A:S.15, A:A.35, A:R.36, A:G.40, A:R.42, A:G.58, A:S.59, A:Y.60, A:Y.60, A:V.235, A:V.235, A:T.426, A:T.426, A:G.434, A:M.436 Water bridges: A:I.14, A:G.16, A:E.34, A:E.34, A:R.42, A:R.42, A:T.43, A:Q.65, A:E.437 Salt bridges: A:R.42, A:R.42 pi-Stacking: A:Y.393 FAD.3: 37 residues within 4Å: Chain B: V.10, G.11, G.12, G.13, I.14, S.15, L.33, E.34, A.35, R.36, G.40, G.41, R.42, T.43, L.56, G.57, G.58, S.59, Y.60, R.233, P.234, V.235, A.263, I.264, P.265, V.294, W.388, Y.393, C.397, Y.398, G.425, T.426, G.434, Y.435, M.436, A.439 Ligands: P1B.4 31 PLIP interactions: 31 interactions with chain B Hydrophobic interactions: B:V.294, B:W.388, B:Y.398 Hydrogen bonds: B:G.12, B:G.13, B:S.15, B:A.35, B:R.36, B:G.40, B:R.42, B:G.58, B:S.59, B:Y.60, B:Y.60, B:V.235, B:V.235, B:T.426, B:G.434, B:M.436 Water bridges: B:I.14, B:G.16, B:E.34, B:E.34, B:R.42, B:R.42, B:T.43, B:Q.65, B:E.437 Salt bridges: B:R.42, B:R.42 pi-Stacking: B:Y.393

2 x P1B: (5R)-5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione(Non-covalent)

P1B.2: 18 residues within 4Å: Chain A: Y.60, P.102, F.103, P.104, W.119, L.164, F.168, L.171, C.172, I.198, I.199, Q.206, I.316, Y.326, F.343, Y.398, Y.435 Ligands: FAD.1 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.103, A:F.103, A:W.119, A:W.119, A:L.164, A:F.168, A:L.171, A:L.171, A:I.199, A:I.199, A:I.316 Hydrogen bonds: A:Y.435 Water bridges: A:Q.206 pi-Stacking: A:Y.326 P1B.4: 18 residues within 4Å: Chain B: Y.60, P.102, F.103, P.104, W.119, L.164, F.168, L.171, C.172, I.198, I.199, Q.206, I.316, Y.326, F.343, Y.398, Y.435 Ligands: FAD.3 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:F.103, B:F.103, B:W.119, B:W.119, B:L.164, B:F.168, B:L.171, B:L.171, B:I.199, B:I.199, B:I.316 Water bridges: B:Q.206 pi-Stacking: B:Y.326

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Binda, C. et al., Molecular Insights Into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs. Acs Med. Chem. Lett. (2012)

Release Date

2012-04-25

Peptides

AMINE OXIDASE [FLAVIN-CONTAINING] B: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

AMINE OXIDASE [FLAVIN-CONTAINING] B

Related Entries With Identical Sequence